GB828847A
(en)
|
1956-12-14 |
1960-02-24 |
Ilford Ltd |
Improvements in or relating to cyanine dyes
|
FR1242962A
(fr)
|
1959-08-25 |
1960-10-07 |
Kodak Pathe |
Nouveau procédé pour la préparation de colorants sensibilisateurs de la série des cyanines et des mérocyanines et produits obtenus
|
GB1268773A
(en)
|
1968-03-15 |
1972-03-29 |
Glaxo Lab Ltd |
NOVEL alpha-CARBOLINE DERIVATIVES, THE PREPARATION THEREOF AND COMPOSITIONS CONTAINING THE SAME
|
DE2844606A1
(de)
|
1978-10-13 |
1980-04-24 |
Bayer Ag |
Heterocyclische farbstoffe
|
JPS54110226A
(en)
|
1978-01-25 |
1979-08-29 |
Bayer Ag |
Dye
|
GB9222253D0
(en)
|
1992-10-23 |
1992-12-09 |
Celltech Ltd |
Chemical compounds
|
GB9304920D0
(en)
|
1993-03-10 |
1993-04-28 |
Celltech Ltd |
Chemical compounds
|
JP3944241B2
(ja)
|
1995-12-18 |
2007-07-11 |
スージェン・インコーポレーテッド |
Aur―1および/またはaur―2関連疾患の診断および処置
|
US7119174B2
(en)
|
1995-12-18 |
2006-10-10 |
Sugen, Inc. |
Diagnosis and treatment of AUR1 and/or AUR2 related disorders
|
US6716575B2
(en)
|
1995-12-18 |
2004-04-06 |
Sugen, Inc. |
Diagnosis and treatment of AUR1 and/or AUR2 related disorders
|
GB9707800D0
(en)
|
1996-05-06 |
1997-06-04 |
Zeneca Ltd |
Chemical compounds
|
GB9622363D0
(en)
|
1996-10-28 |
1997-01-08 |
Celltech Therapeutics Ltd |
Chemical compounds
|
GB9625184D0
(en)
|
1996-12-04 |
1997-01-22 |
Celltech Therapeutics Ltd |
Chemical compounds
|
JP2001507349A
(ja)
|
1996-12-23 |
2001-06-05 |
セルテック セラピューティックス リミテッド |
縮合多環式2−アミノピリミジン誘導体、それらの製造およびたんぱく質チロシンキナーゼ抑制因子としてのそれらの使用
|
GB9705361D0
(en)
|
1997-03-14 |
1997-04-30 |
Celltech Therapeutics Ltd |
Chemical compounds
|
EP1004667B1
(fr)
|
1997-08-15 |
2006-10-18 |
Hiroshima University |
Proteines de regulation de cycle cellulaire
|
EP1005470B1
(fr)
|
1997-08-22 |
2007-08-01 |
AstraZeneca AB |
Derives d'oxindolylquinazoline utiles comme inhibiteurs d'angiogenese
|
US7462605B2
(en)
|
1998-01-23 |
2008-12-09 |
Celmed Oncology (Usa), Inc. |
Phosphoramidate compounds and methods of use
|
US6143480A
(en)
|
1998-09-03 |
2000-11-07 |
Fuji Photo Film Co., Ltd. |
Leuco dye and image recording medium containing the same
|
US6706491B1
(en)
|
1999-04-09 |
2004-03-16 |
The Board Of Trustees Of The University Of Illinois |
Reagents and methods for identifying and modulating expression of genes regulated by p21
|
US20050113460A1
(en)
|
1999-04-30 |
2005-05-26 |
The Regents Of The University Of Michigan |
Compositions and methods relating to novel compounds and targets thereof
|
US6982265B1
(en)
|
1999-05-21 |
2006-01-03 |
Bristol Myers Squibb Company |
Pyrrolotriazine inhibitors of kinases
|
AU6237700A
(en)
|
1999-07-21 |
2001-02-13 |
University Of Massachusetts |
Kinase blocking polypeptides and uses thereof
|
US6787545B1
(en)
|
1999-08-23 |
2004-09-07 |
Shiongi & Co., Ltd. |
Pyrrolotriazine derivatives having spla2-inhibitory activities
|
GB9922171D0
(en)
|
1999-09-21 |
1999-11-17 |
Zeneca Ltd |
Chemical compounds
|
GB9922173D0
(en)
|
1999-09-21 |
1999-11-17 |
Zeneca Ltd |
Chemical compounds
|
CN1391562A
(zh)
|
1999-09-21 |
2003-01-15 |
阿斯特拉曾尼卡有限公司 |
用作药物的喹唑啉衍生物
|
WO2001021594A1
(fr)
|
1999-09-21 |
2001-03-29 |
Astrazeneca Ab |
Composes de quinazoline et compositions pharmaceutiques comprenant lesdits composes
|
MXPA02003436A
(es)
|
1999-10-07 |
2002-08-20 |
Amgen Inc |
Inhibidores de triazina cinasa.
|
US6455525B1
(en)
|
1999-11-04 |
2002-09-24 |
Cephalon, Inc. |
Heterocyclic substituted pyrazolones
|
CA2699568C
(fr)
|
1999-12-24 |
2013-03-12 |
Aventis Pharma Limited |
Azaindoles
|
WO2001055116A2
(fr)
|
2000-01-28 |
2001-08-02 |
Astrazeneca Ab |
Composes chimiques
|
SK14082001A3
(sk)
|
2000-02-05 |
2002-03-05 |
Vertex Pharmaceuticals Incorporated |
Deriváty pyrazolu ako inhibítory ERK a farmaceutická kompozícia, ktorá ich obsahuje
|
WO2001056993A2
(fr)
|
2000-02-05 |
2001-08-09 |
Vertex Pharmaceuticals Incorporated |
Compositions de pyrazole utiles en tant qu'inhibiteurs d'erk
|
EP1209158A1
(fr)
|
2000-11-18 |
2002-05-29 |
Aventis Pharma Deutschland GmbH |
Bêta-carbolines subtituées
|
EP1134221A1
(fr)
|
2000-03-15 |
2001-09-19 |
Aventis Pharma Deutschland GmbH |
Bêta-carbolines substituées comme inhibiteurs de lkB kinase
|
JP2001294772A
(ja)
|
2000-04-10 |
2001-10-23 |
Fuji Photo Film Co Ltd |
着色組成物、インクジェット用インク及びインクジェット記録方法
|
JP2001302667A
(ja)
|
2000-04-28 |
2001-10-31 |
Bayer Ag |
イミダゾピリミジン誘導体およびトリアゾロピリミジン誘導体
|
US6555329B2
(en)
|
2000-06-09 |
2003-04-29 |
Boehringer Ingelheim International Gmbh |
Method for identifying compounds altering higher-order chromatin-dependent chromosome stability
|
US6335342B1
(en)
|
2000-06-19 |
2002-01-01 |
Pharmacia & Upjohn S.P.A. |
Azaindole derivatives, process for their preparation, and their use as antitumor agents
|
MXPA02011974A
(es)
|
2000-06-28 |
2004-09-06 |
Astrazeneca Ab |
Derivados de quinazolina sustituidos y su uso como inhibidores.
|
AU2002222933A1
(en)
|
2000-07-13 |
2002-01-30 |
Millennium Pharamaceuticals, Inc. |
Inhibitors of factor xa
|
US20050009876A1
(en)
|
2000-07-31 |
2005-01-13 |
Bhagwat Shripad S. |
Indazole compounds, compositions thereof and methods of treatment therewith
|
MXPA03001169A
(es)
|
2000-08-10 |
2003-06-30 |
Pharmacia Italia Spa |
Biciclo-pirazoles activos como inhibidores de quinasa, proceso para su preparacion y composiciones farmaceuticas que comprenden los mismos.
|
US6352858B1
(en)
|
2000-09-11 |
2002-03-05 |
Isis Pharmaceuticals, Inc. |
Antisense modulation of BTAK expression
|
US6610677B2
(en)
|
2000-09-15 |
2003-08-26 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
US7473691B2
(en)
|
2000-09-15 |
2009-01-06 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
US6613776B2
(en)
|
2000-09-15 |
2003-09-02 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
US6660731B2
(en)
|
2000-09-15 |
2003-12-09 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
DE60128709T2
(de)
|
2000-09-15 |
2007-12-27 |
Vertex Pharmaceuticals Inc., Cambridge |
Triazol-verbindungen als protein-kinase-inhibitoren
|
US20040019046A1
(en)
|
2000-11-27 |
2004-01-29 |
Paolo Pevarello |
Phenylacetamido-pyrazole derivatives and their use as antitumor agents
|
US6455559B1
(en)
|
2001-07-19 |
2002-09-24 |
Pharmacia Italia S.P.A. |
Phenylacetamido-pyrazole derivatives, process for their preparation and their use as antitumor agents
|
OA12532A
(en)
|
2000-11-28 |
2006-06-02 |
Pfizer Prod Inc |
Salts of a isothiazole-4-carboxamide and their useas anti-hyperproliferation agents.
|
JP2004516297A
(ja)
*
|
2000-12-20 |
2004-06-03 |
ソシエテ・ド・コンセイユ・ド・ルシエルシエ・エ・ダアツプリカーション・シヤンテイフイツク・(エス.セー.エール.アー.エス) |
サイクリン依存性キナーゼ(cdk)及びグリコーゲンシンターゼキナーゼ−3(gsk−3)の阻害剤
|
FR2818278B1
(fr)
|
2000-12-20 |
2003-02-28 |
Sod Conseils Rech Applic |
Inhibiteurs de kinases dependantes des cyclines (cdk) et de la glycogene synthase kinase-3 (gsk-3)
|
KR100947185B1
(ko)
|
2000-12-21 |
2010-03-15 |
버텍스 파마슈티칼스 인코포레이티드 |
단백질 키나제 억제제로서 유용한 피라졸 화합물 및 이를 포함하는 조성물
|
GB0102687D0
(en)
|
2001-02-02 |
2001-03-21 |
Pharmacia & Upjohn Spa |
Oxazolyl-pyrazole derivatives active as kinase inhibitors,process for their preparation and pharmaceutical compositions comprising them
|
MY130778A
(en)
|
2001-02-09 |
2007-07-31 |
Vertex Pharma |
Heterocyclic inhibitiors of erk2 and uses thereof
|
US6864255B2
(en)
|
2001-04-11 |
2005-03-08 |
Amgen Inc. |
Substituted triazinyl amide derivatives and methods of use
|
NZ528210A
(en)
|
2001-05-14 |
2005-04-29 |
Pfizer Prod Inc |
Tartrate salts of 5,8,14-triazatetracyclo[10.3.1.02,11.04,9]-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
|
CA2448076A1
(fr)
|
2001-05-24 |
2002-11-28 |
Masahiko Hayakawa |
Derives de 3-quinoleine-2-(1h)-ylideneindoline-2-one
|
US20030187007A1
(en)
|
2001-05-30 |
2003-10-02 |
Cao Sheldon Xiaodong |
Inhibitors of protein kinase for the treatment of disease
|
MXPA03010961A
(es)
|
2001-05-31 |
2004-02-27 |
Vertex Pharma |
Compuestos de tiazol utiles como inhibidores de proteinas cinasas.
|
DE60214703T2
(de)
|
2001-06-01 |
2007-09-13 |
Vertex Pharmaceuticals Inc., Cambridge |
Thiazolverbindungen, die sich als inhibitoren von proteinkinasen eignen
|
GB0115109D0
(en)
|
2001-06-21 |
2001-08-15 |
Aventis Pharma Ltd |
Chemical compounds
|
GB0115393D0
(en)
|
2001-06-23 |
2001-08-15 |
Aventis Pharma Ltd |
Chemical compounds
|
DK1406899T3
(da)
|
2001-07-19 |
2007-04-02 |
Pfizer Italia Srl |
Phenylacetamidothiazolderivater, fremgangsmåder til deres fremstilling og deres anvendelse som antitumormidler
|
WO2003009852A1
(fr)
|
2001-07-24 |
2003-02-06 |
Merck & Co., Inc. |
Inhibiteurs de tyrosine kinase
|
WO2003012046A2
(fr)
|
2001-07-27 |
2003-02-13 |
The Regents Of The University Of California |
Polymorphisme du gene stk15 (stk6) et methodes de determination du risque de cancer
|
WO2003011287A1
(fr)
|
2001-08-03 |
2003-02-13 |
Vertex Pharmaceuticals Incorporated |
Derives de pyrazole comme inhibiteurs de gsk-3
|
MXPA04000920A
(es)
|
2001-08-06 |
2004-04-02 |
Pharmacia Italia Spa |
Derivados de aminoisoxazol activos como inhibidores de la cinasa.
|
US20030073692A1
(en)
|
2001-08-07 |
2003-04-17 |
Pharmacia & Upjohn S.P.A. |
Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
|
WO2003020276A1
(fr)
|
2001-08-30 |
2003-03-13 |
Merck & Co., Inc. |
Inhibiteurs de tyrosine kinase
|
US6806272B2
(en)
|
2001-09-04 |
2004-10-19 |
Boehringer Ingelheim Pharma Kg |
Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
|
CA2461567C
(fr)
|
2001-09-19 |
2008-08-19 |
Pharmacia Corporation |
Composes substitues de sulfamide benzene de pyrazolyl destines au traitement des inflammations
|
CA2460939C
(fr)
|
2001-09-19 |
2008-07-29 |
Pharmacia Corporation |
Composes de pyrazolyl substitues pour le traitement de l'inflammation
|
US6956052B2
(en)
|
2001-09-19 |
2005-10-18 |
Pharmacia Corporation |
Substituted pyrazolyl compounds for the treatment of inflammation
|
BR0212613A
(pt)
|
2001-09-19 |
2004-08-31 |
Pharmacia Corp |
Compostos de indazol substituìdos para o tratamento de inflamação
|
EP1820503B1
(fr)
|
2001-09-26 |
2012-02-22 |
Pfizer Italia S.r.l. |
Dérivés d'aminoindazole actifs en tant qu'inhibiteurs de la kinase, leur procédé de préparation et compositions pharmaceutiques les contenant
|
GB0124299D0
(en)
|
2001-10-10 |
2001-11-28 |
Astrazeneca Ab |
Crystal structure of enzyme and uses thereof
|
ATE407678T1
(de)
|
2001-10-17 |
2008-09-15 |
Boehringer Ingelheim Pharma |
Pyrimidinderivate, arzneimittel enthaltend diese verbindungen, deren verwendung und verfahren zu ihrer herstellung
|
US20040010027A1
(en)
|
2001-12-17 |
2004-01-15 |
Pharmacia & Upjohn Spa |
Hydroxphenyl-pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical comositions comprising them
|
SE0104340D0
(sv)
|
2001-12-20 |
2001-12-20 |
Astrazeneca Ab |
New compounds
|
DK1463506T3
(da)
|
2001-12-24 |
2010-01-11 |
Astrazeneca Ab |
Substituerede quinazolin-derivater som inhibitorer af aurora-kinaser
|
EA011488B1
(ru)
|
2002-02-01 |
2009-04-28 |
Ариад Джин Терапьютикс, Инк. |
Фосфорсодержащие соединения и их получение
|
FR2836914B1
(fr)
|
2002-03-11 |
2008-03-14 |
Aventis Pharma Sa |
Indazoles substitues, compositions les contenant, procede de fabrication et utilisation
|
AU2003220299A1
(en)
|
2002-03-15 |
2003-09-29 |
Vertex Pharmaceuticals, Inc. |
Azinylaminoazoles as inhibitors of protein kinases
|
ATE365733T1
(de)
|
2002-03-15 |
2007-07-15 |
Vertex Pharma |
Zusammensetzungen brauchbar als protein-kinase- inhibitoren
|
WO2003078426A1
(fr)
|
2002-03-15 |
2003-09-25 |
Vertex Pharmaceuticals, Inc. |
Azolylaminoazines en tant qu'inhibiteurs de proteines kinases
|
DE60332604D1
(de)
|
2002-03-15 |
2010-07-01 |
Vertex Pharma |
Azolylaminoazine als proteinkinasehemmer
|
SE0200979D0
(sv)
|
2002-03-28 |
2002-03-28 |
Astrazeneca Ab |
New compounds
|
AU2003230802B2
(en)
|
2002-04-08 |
2007-08-09 |
Merck Sharp & Dohme Corp. |
Inhibitors of Akt activity
|
WO2003087395A2
(fr)
|
2002-04-15 |
2003-10-23 |
Inserm |
Procedes d'identification d'agents antitumoraux inhibiteurs des interactions de rasgap avec la kinase aurora
|
US7304061B2
(en)
|
2002-04-26 |
2007-12-04 |
Vertex Pharmaceuticals Incorporated |
Heterocyclic inhibitors of ERK2 and uses thereof
|
WO2003092607A2
(fr)
|
2002-05-01 |
2003-11-13 |
Vertex Pharmaceuticals Incorporated |
Structure cristalline de la proteine aurora-2 et poches de liaison associees
|
MXPA04011417A
(es)
|
2002-05-17 |
2005-02-14 |
Pharmacia Italia Spa |
Derivados de aminoindazol activos como inhibidores de cinasa, procedimiento para su preparacion y composiciones farmaceuticas que los comprenden.
|
WO2003101983A1
(fr)
|
2002-05-31 |
2003-12-11 |
Yamanouchi Pharmaceutical Co., Ltd. |
Derive tetrahydropyrane
|
US6989451B2
(en)
|
2002-06-04 |
2006-01-24 |
Valeant Research & Development |
Heterocyclic compounds and uses thereof
|
AU2002311176A1
(en)
|
2002-06-12 |
2003-12-31 |
Axia Biosciences, Inc. |
Chfr protein-catalyzed polyubiquitination of aurora kinase a and aurora kinase b
|
FR2840905B1
(fr)
|
2002-06-12 |
2006-07-07 |
Centre Nat Rech Scient |
Anticorps monoclonal anti-aurora-a, son procede d'obtention, et ses utilisations dans le diagnostic et le traitement des cancers
|
CA2486215A1
(fr)
|
2002-06-14 |
2003-12-24 |
Merck & Co., Inc. |
Inhibiteurs de kinesine mitotique
|
MY141867A
(en)
|
2002-06-20 |
2010-07-16 |
Vertex Pharma |
Substituted pyrimidines useful as protein kinase inhibitors
|
EP1554269A1
(fr)
|
2002-07-09 |
2005-07-20 |
Vertex Pharmaceuticals Incorporated |
Imidazoles, oxazoles et thiazoles presentant des activites d'inhibition des proteines kinases
|
AU2003253880A1
(en)
|
2002-07-15 |
2004-02-02 |
Sugen, Inc. |
Novel kinases
|
ES2304531T3
(es)
|
2002-07-17 |
2008-10-16 |
Pfizer Italia S.R.L. |
Derivados heterobiciclicos de pirazol como inhibidores de quinasa.
|
AU2003250040A1
(en)
|
2002-07-25 |
2004-02-23 |
Pharmacia Italia S.P.A |
Condensed heterocyclic pyrazole derivatives as kinase inhibitors
|
JP2005537290A
(ja)
|
2002-07-25 |
2005-12-08 |
ファルマシア・イタリア・エス・ピー・エー |
キナーゼ阻害剤として活性なビシクロピラゾール類、その製造方法、およびそれを含有する薬学的組成物
|
MXPA05000947A
(es)
|
2002-07-25 |
2005-05-16 |
Pharmacia Italia Spa |
Biciclo-pirazoles activos como inhibidores de cinasa, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
|
PL375447A1
(en)
|
2002-08-14 |
2005-11-28 |
Vertex Pharmaceuticals Incorporated |
Protein kinase inhibitors and uses thereof
|
PE20050081A1
(es)
|
2002-09-23 |
2005-03-01 |
Schering Corp |
Nuevas imidazopirazinas como inhibidores de cinasas dependientes de ciclinas
|
US20040157804A1
(en)
|
2002-10-16 |
2004-08-12 |
Gilead Sciences, Inc. |
Pre-organized tricyclic integrase inhibitor compounds
|
WO2004037814A1
(fr)
|
2002-10-25 |
2004-05-06 |
Vertex Pharmaceuticals Incorporated |
Compositions indazolinones utiles en tant qu'inhibiteurs des kinases
|
US20040102360A1
(en)
|
2002-10-30 |
2004-05-27 |
Barnett Stanley F. |
Combination therapy
|
GB0226583D0
(en)
|
2002-11-14 |
2002-12-18 |
Cyclacel Ltd |
Compounds
|
US6909001B2
(en)
|
2002-12-12 |
2005-06-21 |
Pharmacia Corporation |
Method of making tricyclic aminocyanopyridine compounds
|
UA81790C2
(uk)
|
2002-12-19 |
2008-02-11 |
Фармация Италия С.П.А. |
Заміщені піролопіразольні похідні як інгібітори кінази
|
WO2004056812A1
(fr)
|
2002-12-23 |
2004-07-08 |
Astrazeneca Ab |
Derives de 4-(pyridin-4-ylamino)-quinazoline utilises comme agents anticancereux
|
JP2006516138A
(ja)
|
2002-12-24 |
2006-06-22 |
アストラゼネカ アクチボラグ |
キナゾリン化合物
|
JP2006512387A
(ja)
|
2002-12-24 |
2006-04-13 |
アストラゼネカ アクチボラグ |
化合物
|
ES2290529T3
(es)
|
2002-12-24 |
2008-02-16 |
Astrazeneca Ab |
Derivados de fosfonooxiquinazolina y su uso farmaceutico.
|
CL2004000016A1
(es)
|
2003-01-21 |
2005-04-15 |
Wyeth Corp |
Compuesto derivado de cloruro de 4-amino-2-butenoilo o una sal farmaceuticamente aceptable del mismo; procedimiento para preparar dicho compuesto, util como intermediario en la sintesis de compuestos inhibidores de proteina quinasa tirosina.
|
EP1590334B1
(fr)
|
2003-01-30 |
2009-08-19 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Derives de 2,4-diaminopyrimidine utiles en tant qu'inhibiteurs de l'enzyme pkc-theta
|
WO2004070062A2
(fr)
|
2003-02-04 |
2004-08-19 |
Wyeth |
Compositions et techniques de diagnostic et de traitement de cancers
|
WO2004071390A2
(fr)
|
2003-02-14 |
2004-08-26 |
Applied Research Systems Ars Holding N.V. |
Derives de piperazine-2-carboxamide
|
MXPA05008688A
(es)
|
2003-02-17 |
2005-10-05 |
Pharmacia Italia Spa |
Derivados tetraciclicos de pirazol como inhibidores de la cinasa, procedimiento para su preparacion y composiciones farmaceuticas que los comprenden.
|
US6861422B2
(en)
|
2003-02-26 |
2005-03-01 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
|
BR0318145A
(pt)
|
2003-02-26 |
2006-02-21 |
Boehringer Ingelheim Pharma |
dihidropteridinonas, processos para a sua preparação e sua aplicação como medicamento
|
AR050920A1
(es)
|
2003-03-07 |
2006-12-06 |
Astrazeneca Ab |
Enantiomeros de heterociclos fusionados seleccionados y usos de los mismos
|
US20070037790A1
(en)
|
2003-03-11 |
2007-02-15 |
Francesca Abrate |
Bicyclo-pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
|
AU2004221881A1
(en)
|
2003-03-13 |
2004-09-30 |
Vertex Pharmaceuticals Incorporated |
Compositions useful as protein kinase inhibitors
|
JP2006521398A
(ja)
|
2003-03-28 |
2006-09-21 |
サイオス・インコーポレーテツド |
TGFβの二−環式ピリミジン阻害剤
|
US20070179161A1
(en)
|
2003-03-31 |
2007-08-02 |
Vernalis (Cambridge) Limited. |
Pyrazolopyrimidine compounds and their use in medicine
|
WO2004090106A2
(fr)
|
2003-04-04 |
2004-10-21 |
Vertex Pharmaceuticals Incorporated |
Structures cristallines de complexes proteiques humains de la pim-1 kinase et poches de liaison de ces structures, et leurs utilisations dans la conception de medicaments
|
CL2004000797A1
(es)
|
2003-04-16 |
2005-05-27 |
Astrazeneca Ab |
Compuestos derivados de quinazolina, inhibidores de aurora quinasa; procedimiento de preparacion; composicion farmaceutica; y su uso para preparar un medicamento para tratar cancer colorrectal, de mama, de pulmon, de prostata, de vejiga, renal o panc
|
CN100422158C
(zh)
|
2003-04-24 |
2008-10-01 |
麦克公司 |
Akt活性抑制剂
|
CA2522430A1
(fr)
|
2003-04-24 |
2004-11-11 |
Merck & Co., Inc. |
Inhibiteurs de l'activite akt
|
ATE512957T1
(de)
|
2003-04-24 |
2011-07-15 |
Merck Sharp & Dohme |
Hemmer der akt aktivität
|
EP1631548B1
(fr)
|
2003-04-24 |
2009-10-28 |
Merck & Co., Inc. |
Inhibiteurs de l'activite de l'akt
|
US20040242559A1
(en)
|
2003-04-25 |
2004-12-02 |
Aventis Pharma S.A. |
Novel indole derivatives, preparation thereof as medicinal products and pharmaceutical compositions, and especially as KDR inhibitors
|
JP2007500212A
(ja)
|
2003-05-01 |
2007-01-11 |
ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン |
新規化合物およびその標的に関する組成物および方法
|
ES2350837T3
(es)
|
2003-05-01 |
2011-01-27 |
Bristol-Myers Squibb Company |
Compuestos de pirazol-amida sustituidos con arilo útiles como inhibidores de quinasas.
|
US20050125852A1
(en)
|
2003-05-09 |
2005-06-09 |
Sugen, Inc. |
Novel kinases
|
OA13170A
(en)
|
2003-05-22 |
2006-12-13 |
Pharmacia Italia Spa |
Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors.
|
US7345046B2
(en)
|
2003-05-30 |
2008-03-18 |
Chiron Corporation |
Heteroaryl-fused pyrimidinyl compounds as anticancer agents
|
ATE401080T1
(de)
|
2003-06-02 |
2008-08-15 |
Astrazeneca Ab |
(3-((chinazolin-4-yl)amino)-1h-pyrazol-1- yl)acetamid derivate und verwandte verbindungen als aurora kinase inhibitoren zur behandlung von proliferativen erkrankungen wie krebs
|
TW200505452A
(en)
|
2003-06-17 |
2005-02-16 |
Astrazeneca Ab |
Chemical compounds
|
PT1636225E
(pt)
|
2003-06-20 |
2010-05-03 |
Novartis Vaccines & Diagnostic |
Compostos piridino[1,2-a]pirimidin-4-ona como agentes anti-cancerígenos
|
WO2005009348A2
(fr)
|
2003-06-25 |
2005-02-03 |
Ariad Pharmaceuticals, Inc. |
Derives de purine substitues
|
ATE423111T1
(de)
|
2003-07-03 |
2009-03-15 |
Euro Celtique Sa |
2-pyridin alkyne derivaten und ihre verwendung für die schmerzbehandlung
|
WO2005002571A1
(fr)
|
2003-07-03 |
2005-01-13 |
Cambridge University Technical Services Ltd |
Utilisation d'inhibiteurs des aurora kinases pour reduire la resistance des cellules cancereuses
|
TWI372050B
(en)
|
2003-07-03 |
2012-09-11 |
Astex Therapeutics Ltd |
(morpholin-4-ylmethyl-1h-benzimidazol-2-yl)-1h-pyrazoles
|
GB0315657D0
(en)
|
2003-07-03 |
2003-08-13 |
Astex Technology Ltd |
Pharmaceutical compounds
|
US20050032869A1
(en)
|
2003-07-08 |
2005-02-10 |
Pharmacia Italia S.P.A. |
Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
|
GB0315966D0
(en)
|
2003-07-08 |
2003-08-13 |
Cyclacel Ltd |
Compounds
|
US7141568B2
(en)
|
2003-07-09 |
2006-11-28 |
Pfizer Italia S.R.L. |
Pyrrolo[3,4-c]pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
|
WO2005016252A2
(fr)
|
2003-07-11 |
2005-02-24 |
Ariad Gene Therapeutics, Inc. |
Macrocycles contenant du phosphore
|
CA2531333A1
(fr)
|
2003-07-16 |
2005-02-10 |
Janssen Pharmaceutica N.V. |
Derives de triazolopyrimidine en tant qu'inhibiteurs de glycogene synthase kinase 3
|
JP2007526894A
(ja)
|
2003-07-16 |
2007-09-20 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
グリコーゲンシンターゼキナーゼ3インヒビターとしてのトリアゾロピリミジン誘導体
|
ES2337150T3
(es)
|
2003-07-21 |
2010-04-21 |
Merck Serono Sa |
Alquinilaril carboxamidas.
|
EP1648878B9
(fr)
|
2003-07-24 |
2011-03-16 |
Euro-Celtique S.A. |
Composes de piperidine et compositions pharmaceutiques les contenant
|
US20050026984A1
(en)
|
2003-07-29 |
2005-02-03 |
Aventis Pharma S.A. |
Substituted thieno [2,3-c] pyrazoles and their use as medicinal products
|
US7619059B2
(en)
|
2003-07-29 |
2009-11-17 |
Life Technologies Corporation |
Bimolecular optical probes
|
EP1648887A1
(fr)
|
2003-07-30 |
2006-04-26 |
Cyclacel Limited |
Derives de pyridinylamino-pyrimidine utiles comme inhibiteurs de la proteine kinase
|
BRPI0412347A
(pt)
|
2003-07-30 |
2006-09-05 |
Cyclacel Ltd |
2-aminofenil-4-fenilpiridinas como inibidores de quinase
|
US7094791B2
(en)
|
2003-07-31 |
2006-08-22 |
Avalon Pharmaceuticals, Inc. |
Derivatives of 3-hydroxy-pyrrole-2,4-dicarboxylic acid and uses thereof
|
US7279575B2
(en)
|
2003-08-08 |
2007-10-09 |
Pfizer Italia S.R.L. |
Pyrimidylpyrrole derivatives active as kinase inhibitors
|
US20050043346A1
(en)
|
2003-08-08 |
2005-02-24 |
Pharmacia Italia S.P.A. |
Pyridylpyrrole derivatives active as kinase inhibitors
|
US7157476B2
(en)
|
2003-08-20 |
2007-01-02 |
Vertex Pharmaceuticals Incorporated |
Aminofurazan compounds useful as protein kinase inhibitors
|
TWI339206B
(en)
|
2003-09-04 |
2011-03-21 |
Vertex Pharma |
Compositions useful as inhibitors of protein kinases
|
JP2007505085A
(ja)
|
2003-09-12 |
2007-03-08 |
アプライド リサーチ システムズ エーアールエス ホールディング ナームロゼ フェンノートシャップ |
ベンゾイミダゾールアセトニトリル
|
AU2004272346A1
(en)
|
2003-09-16 |
2005-03-24 |
Astrazeneca Ab |
Quinazoline derivatives
|
CA2538884C
(fr)
|
2003-09-16 |
2010-09-21 |
Astrazeneca Ab |
Derives de quinazoline utilises comme inhibiteurs de la tyrosine kinase
|
US20080234263A1
(en)
|
2003-09-16 |
2008-09-25 |
Laurent Francois Andre Hennequin |
Quinazoline Derivatives
|
AU2003270848A1
(en)
|
2003-09-17 |
2005-04-27 |
Sunesis Pharmaceuticals, Inc. |
Identification of kinase inhibitors
|
CA2539320A1
(fr)
|
2003-09-17 |
2005-03-31 |
Icos Corporation |
Utilisation d'inhibiteurs de la chk1 pour lutter contre la proliferation cellulaire
|
CA2537325A1
(fr)
|
2003-09-19 |
2005-03-31 |
Gilead Sciences, Inc. |
Composes d'aza-quinolinol phosphonate inhibiteurs de l'integrase
|
US20050085531A1
(en)
|
2003-10-03 |
2005-04-21 |
Hodge Carl N. |
Thiophene-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof
|
US7326712B2
(en)
|
2003-10-14 |
2008-02-05 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Substituted tricyclic compounds as protein kinase inhibitors
|
CN1897950A
(zh)
|
2003-10-14 |
2007-01-17 |
惠氏公司 |
稠合芳基和杂芳基衍生物及其使用方法
|
WO2005035527A1
(fr)
|
2003-10-14 |
2005-04-21 |
Pharmacia Corporation |
Composes de pyrazinone substitues pour le traitement de l'inflammation
|
AU2004283137A1
(en)
|
2003-10-17 |
2005-05-06 |
Astrazeneca Ab |
4-(pyrazol-3-ylamino) pyrimidine derivatives for use in the treatment of cancer
|
AU2004285745A1
(en)
|
2003-10-21 |
2005-05-12 |
Cyclacel Limited |
Pyrimidin-4-YL-3, 4-thione compounds and their use in therapy
|
WO2005037797A1
(fr)
|
2003-10-21 |
2005-04-28 |
Pharmacia Corporation |
Composes d'uree de pyrazole substituee utiles dans le traitement d'inflammations
|
EP1678146A1
(fr)
|
2003-10-23 |
2006-07-12 |
Pharmacia Corporation |
Composes de pyrimidine utiles pour le traitement des inflammations
|
WO2005044270A1
(fr)
|
2003-11-04 |
2005-05-19 |
4Sc Ag |
Derives de l'oxadiazolopyrazine utilises comme composes pharmaceutiquement actifs
|
EP1692113B1
(fr)
|
2003-11-14 |
2017-09-27 |
Lorus Therapeutics Inc. |
Imidazoles d'aryle et leur utilisation comme agents anticancereux
|
MY141220A
(en)
|
2003-11-17 |
2010-03-31 |
Astrazeneca Ab |
Pyrazole derivatives as inhibitors of receptor tyrosine kinases
|
AU2004293035A1
(en)
|
2003-11-19 |
2005-06-09 |
Signal Pharmaceuticals, Llc |
Methods of treating diseases and disorders by targeting multiple kinases
|
FR2864084B1
(fr)
|
2003-12-17 |
2006-02-10 |
Aventis Pharma Sa |
Nouveaux derives organophosphores des indazoles et leur utilisation comme medicaments
|
JP4728965B2
(ja)
|
2003-12-17 |
2011-07-20 |
エスジーエックス ファーマシューティカルズ、インコーポレイテッド |
プロテインキナーゼモジュレーターとしての二環ピラゾロ−縮合化合物
|
GB0330042D0
(en)
|
2003-12-24 |
2004-01-28 |
Pharmacia Italia Spa |
Pyrrolo [2,3-b] pyridine derivatives active as kinase inhibitors process for their preparation and pharmaceutical compositions them
|
GB0330043D0
(en)
|
2003-12-24 |
2004-01-28 |
Pharmacia Italia Spa |
Pyrrolo [2,3-b] pyridine derivatives active as kinase inhibitors process for their preparation and pharmaceutical compositions comprising them
|
EP1704416A2
(fr)
|
2004-01-16 |
2006-09-27 |
Ipsogen |
Etablissement de profils d'expression de proteines et prognose du cancer du sein
|
US7855295B2
(en)
|
2004-01-23 |
2010-12-21 |
Novartis Vaccines And Diagnostics, Inc. |
Tetrahydrocarboline compounds as anticancer agents
|
TW200526204A
(en)
|
2004-02-03 |
2005-08-16 |
Pharmacia Italia Spa |
1h-thieno[2,3-c]pyrazole derivatives useful as kinase inhibitors
|
FR2865934B1
(fr)
*
|
2004-02-05 |
2006-05-05 |
Sanofi Synthelabo |
Utilisation de derives d'indolizine 1,2,3 substitues, inhibiteurs des fgfs, pour la preparation de medicaments utiles pour le traitement de maladies liees a une angiogenese pathologique choroidienne
|
GB0402653D0
(en)
|
2004-02-06 |
2004-03-10 |
Cyclacel Ltd |
Compounds
|
AR047969A1
(es)
|
2004-02-25 |
2006-03-15 |
Schering Corp |
Pirazolotriazinas como inhibidores de quinasa
|
US20050288347A1
(en)
|
2004-03-26 |
2005-12-29 |
Hodge Carl N |
Certain triazole-based compounds, compositions, and uses thereof
|
TWI465437B
(zh)
|
2004-03-30 |
2014-12-21 |
Vertex Pharma |
適合作為jak及其它蛋白質激酶抑制劑之氮雜吲哚
|
JP2007530654A
(ja)
|
2004-03-30 |
2007-11-01 |
ファイザー・プロダクツ・インク |
シグナル伝達阻害剤の組合せ
|
FR2868421B1
(fr)
|
2004-04-01 |
2008-08-01 |
Aventis Pharma Sa |
Nouveaux benzothiazoles et leur utilisation comme medicaments
|
US8076338B2
(en)
|
2004-04-23 |
2011-12-13 |
Exelixis, Inc. |
Kinase modulators and methods of use
|
US20050250829A1
(en)
|
2004-04-23 |
2005-11-10 |
Takeda San Diego, Inc. |
Kinase inhibitors
|
TW200538453A
(en)
|
2004-04-26 |
2005-12-01 |
Bristol Myers Squibb Co |
Bicyclic heterocycles as kinase inhibitors
|
WO2005105777A1
(fr)
|
2004-05-05 |
2005-11-10 |
Pharmacia & Upjohn Company Llc |
Composes d'amide a substitution de thiophene pour le traitement de l'inflammation.
|
MXPA06012613A
(es)
|
2004-05-07 |
2007-01-31 |
Amgen Inc |
Derivados heterociclicos nitrogenados como moduladores de proteina cinasa y uso para el tratamiento de angiogenesis y cancer.
|
EP1771450B9
(fr)
|
2004-05-14 |
2008-12-24 |
Millennium Pharmaceuticals, Inc. |
Composés et procée pour l'inhibition de progression mitotique
|
JP4812763B2
(ja)
|
2004-05-18 |
2011-11-09 |
ライジェル ファーマシューティカルズ, インコーポレイテッド |
シクロアルキル置換ピリミジンジアミン化合物およびそれらの用途
|
EP1598343A1
(fr)
|
2004-05-19 |
2005-11-23 |
Boehringer Ingelheim International GmbH |
Dérivés de 2-arylaminopyrimidines comme des inhibiteurs de PLK
|
JPWO2005113550A1
(ja)
|
2004-05-20 |
2008-03-27 |
三菱ウェルファーマ株式会社 |
アミノピリミジン誘導体及びその医薬としての用途
|
DK1753723T3
(da)
|
2004-05-21 |
2008-10-20 |
Novartis Vaccines & Diagnostic |
Substituerede quinolinderivater som mitotiske kinesininhibitorer
|
WO2005117943A2
(fr)
|
2004-05-27 |
2005-12-15 |
Vertex Pharmaceuticals Incorporated |
Biomarqueurs pour le suivi d'inhibition de la voie de l'inosine monophosphate deshydrogenase (impdh)
|
WO2005118587A1
(fr)
|
2004-06-02 |
2005-12-15 |
Takeda Pharmaceutical Company Limited |
Dérivé d’indole et usage pour le traitement du cancer
|
US7452887B2
(en)
|
2004-06-04 |
2008-11-18 |
Amphora Discovery Corporation |
Quinoline- and isoquinoline-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof
|
CA2569277A1
(fr)
|
2004-06-04 |
2005-12-15 |
Pfizer Products Inc. |
Methode de traitement de croissances cellulaires anormales
|
FR2871158A1
(fr)
*
|
2004-06-04 |
2005-12-09 |
Aventis Pharma Sa |
Indazoles substitues, compositions les contenant, procede de fabrication et utilisation
|
US20080153869A1
(en)
|
2004-06-14 |
2008-06-26 |
Bressi Jerome C |
Kinase Inhibitors
|
JP2008502666A
(ja)
|
2004-06-15 |
2008-01-31 |
アストラゼネカ アクチボラグ |
抗癌剤としての置換キナゾロン類
|
BRPI0510929A
(pt)
|
2004-06-18 |
2007-07-17 |
Chiron Corp |
derivados de n-(1-(1-benzil-4-fenil-1h-imidazol-2-il)-2,2-dimetilpropil) benzamida e compostos relacionados como inibidores de proteìna de eixo de kinesin (ksp) para o tratamento de cáncer
|
DE102004029784A1
(de)
*
|
2004-06-21 |
2006-01-05 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue 2-Benzylaminodihydropteridinone, Verfahren zur deren Herstellung und deren Verwendung als Arzneimittel
|
EP1765820A4
(fr)
|
2004-06-23 |
2010-07-21 |
Irm Llc |
Composes et compositions utilises en tant qu'inhibiteurs des proteines kinases
|
CN1972934A
(zh)
|
2004-06-28 |
2007-05-30 |
奥坦纳医药公司 |
4,6-二取代嘧啶及其作为蛋白激酶抑制剂的用途
|
US7253167B2
(en)
|
2004-06-30 |
2007-08-07 |
Bristol-Myers Squibb Company |
Tricyclic-heteroaryl compounds useful as kinase inhibitors
|
EP1773326A4
(fr)
|
2004-07-01 |
2009-07-22 |
Merck & Co Inc |
Inhibiteurs de la kinesine mitotique
|
CA2571824A1
(fr)
|
2004-07-01 |
2006-01-19 |
Merck & Co., Inc. |
Inhibiteurs de kinesine mitotique
|
TW200616974A
(en)
|
2004-07-01 |
2006-06-01 |
Astrazeneca Ab |
Chemical compounds
|
US20080004270A1
(en)
|
2004-07-05 |
2008-01-03 |
Astex Therapeutics Limited |
3,4-Disubstituted Pyrazoles as Cyclin Dependent Kinases (Cdk) or Aurora Kinase or Glycogen Synthase 3 (Gsk-3) Inhibitors
|
EP1765791A1
(fr)
|
2004-07-08 |
2007-03-28 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Dérivés de pyrimidine utiles comme inhibiteurs de la pkc-thêta
|
CA2573378A1
(fr)
|
2004-07-12 |
2006-01-19 |
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. |
Derives amidiques inhibiteurs de l'histone deacetylase
|
AU2005261501A1
(en)
|
2004-07-12 |
2006-01-19 |
Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa |
Amide derivatives as inhibitors of histone deacetylase
|
DE102004034623A1
(de)
*
|
2004-07-16 |
2006-02-02 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Neue 6-Formyl-tetrahydropteridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
DE602005024274D1
(de)
|
2004-07-16 |
2010-12-02 |
Sunesis Pharmaceuticals Inc |
Als aurora-kinase-inhibitoren nutzbare thienopyrimidine
|
US20080261821A1
(en)
|
2004-07-21 |
2008-10-23 |
The Regents Of Te University Of California |
Mechanism-Based Crosslinkers
|
AU2005263969A1
(en)
|
2004-07-22 |
2006-01-26 |
Astrazeneca Ab |
Fused pyrimidones useful in the treatment and the prevention of cancer
|
EP1781647A2
(fr)
|
2004-07-22 |
2007-05-09 |
Astex Therapeutics Limited |
Derives de thiazole et isothiazole comme inhibiteurs de proteine kinases
|
CA2573362A1
(fr)
|
2004-07-27 |
2006-02-09 |
Sgx Pharmaceuticals, Inc. |
Modulateurs de kinases a base de pyrrolopyridine
|
EP1782315A4
(fr)
|
2004-07-30 |
2009-06-24 |
Rosetta Inpharmatics Llc |
Pronostic de patients atteints d'un cancer du sein
|
BRPI0514094A
(pt)
|
2004-08-02 |
2008-05-27 |
Osi Pharm Inc |
composto, composição, e, método de tratamento de distúrbio hiperproliferativo
|
US20060141549A1
(en)
|
2004-08-03 |
2006-06-29 |
Sudipta Mahajan |
Cell-based kinase assay
|
WO2006023083A1
(fr)
|
2004-08-12 |
2006-03-02 |
Merck & Co., Inc. |
Inhibiteurs de kinesine mitotiques
|
CA2575466A1
(fr)
|
2004-08-13 |
2006-02-23 |
Genentech, Inc. |
Composes a base de 2-amido-thiazole presentant une activite inhibitrice enzymatique utilisant de l'adenosine triphosphate (atp), et compositions, et leurs utilisations
|
JP2008510013A
(ja)
|
2004-08-18 |
2008-04-03 |
メルク エンド カムパニー インコーポレーテッド |
有糸分裂キネシン阻害剤
|
US7550598B2
(en)
|
2004-08-18 |
2009-06-23 |
Takeda Pharmaceutical Company Limited |
Kinase inhibitors
|
CA2576168A1
(fr)
|
2004-08-18 |
2006-03-02 |
Merck & Co., Inc. |
Inhibiteurs de kinesines mitotiques
|
US7521457B2
(en)
|
2004-08-20 |
2009-04-21 |
Boehringer Ingelheim International Gmbh |
Pyrimidines as PLK inhibitors
|
CA2576172A1
(fr)
|
2004-08-23 |
2006-04-06 |
Merck & Co., Inc. |
Inhibiteurs de l'activite de akt
|
WO2006021547A1
(fr)
|
2004-08-26 |
2006-03-02 |
Boehringer Ingelheim International Gmbh |
Pteridinones utilisees en tant qu'inhibiteurs des plk (polo-like-kinases)
|
WO2006021548A1
(fr)
|
2004-08-27 |
2006-03-02 |
Boehringer Ingelheim International Gmbh |
Dihydropteridinones, leur procede de production, et leur utilisation en tant que medicaments
|
US20060078617A1
(en)
|
2004-08-27 |
2006-04-13 |
Fritz Schueckler |
Pharmaceutical compositions for the treatment of cancer
|
MY191349A
(en)
|
2004-08-27 |
2022-06-17 |
Bayer Pharmaceuticals Corp |
New pharmaceutical compositions for the treatment of hyper-proliferative disorders
|
WO2006026597A2
(fr)
|
2004-08-30 |
2006-03-09 |
Smithkline Beecham Corporation |
Nouvelles compositions et procedes de traitement
|
WO2006024836A1
(fr)
|
2004-09-01 |
2006-03-09 |
Astrazeneca Ab |
Dérivés de quinazolinone et utilisation de ces dérivés en tant qu'inhibiteurs du b-raf
|
GB0419416D0
(en)
|
2004-09-01 |
2004-10-06 |
Inst Of Ex Botany Ascr |
4-Arylazo-3,5-Diamino-Pyrazole compounds and use thereof
|
AR050926A1
(es)
|
2004-09-03 |
2006-12-06 |
Astrazeneca Ab |
Derivados de benzamida como inhibidores de la histonadesacetilasa(hdac)
|
WO2006036883A2
(fr)
|
2004-09-24 |
2006-04-06 |
Janssen Pharmaceutica, N.V. |
Inhibiteurs imidazo{4,5-b}pyrazinone de proteines kinases
|
TW200624431A
(en)
|
2004-09-24 |
2006-07-16 |
Hoffmann La Roche |
Phthalazinone derivatives, their manufacture and use as pharmaceutical agents
|
WO2006036941A2
(fr)
|
2004-09-27 |
2006-04-06 |
Kosan Biosciences Incorporated |
Inhibiteurs de kinases specifiques
|
US20060069101A1
(en)
|
2004-09-27 |
2006-03-30 |
Kim Kyoung S |
Prodrugs of protein tyrosine kinase inhibitors
|
CN102766142A
(zh)
|
2004-10-04 |
2012-11-07 |
千禧药品公司 |
有效作为蛋白激酶抑制剂的内酰胺化合物
|
FR2876377B1
(fr)
*
|
2004-10-11 |
2007-03-16 |
Univ Claude Bernard Lyon |
Nouveaux derives de 9h-pyrido[2,3-b]indole, leur procede de preparation, ainsi que les compositions pharmaceutiques contenant de tels composes
|
WO2006040520A1
(fr)
*
|
2004-10-12 |
2006-04-20 |
Astrazeneca Ab |
Derives de quinazoline
|
JP2008516939A
(ja)
|
2004-10-15 |
2008-05-22 |
アストラゼネカ アクチボラグ |
化学化合物
|
US7855205B2
(en)
|
2004-10-29 |
2010-12-21 |
Janssen Pharmaceutica Nv |
Pyrimidinyl substituted fused-pyrrolyl compounds useful in treating kinase disorders
|
CA2585638C
(fr)
|
2004-10-29 |
2014-05-06 |
Banyu Pharmaceutical Co., Ltd. |
Derives d'aminopyridine presentant une action inhibitrice selective de l'aurora a
|
EP1814882A1
(fr)
|
2004-11-22 |
2007-08-08 |
Vertex Pharmaceuticals Incorporated |
Pyrrolopyrazines et pyrazolopyrazines convenant inhibiteurs de proteines-kinases
|
GB0427917D0
(en)
|
2004-12-21 |
2005-01-26 |
Astrazeneca Ab |
Chemical compounds
|
ITPI20040099A1
(it)
|
2004-12-24 |
2005-03-24 |
Maurizio Pacini |
Sistema di realizzazione di tappeto erboso mediante micro-plantule preradicate
|
JP2008526721A
(ja)
|
2004-12-30 |
2008-07-24 |
アステックス、セラピューティックス、リミテッド |
Cdk、gsk及びオーロラキナーゼの活性を調節するチアゾールおよびイソチアゾール誘導体
|
NZ555982A
(en)
|
2004-12-30 |
2011-01-28 |
Astex Therapeutics Ltd |
Pyrazole compounds that modulate the activity of CDK, GSK and aurora kinases
|
WO2006070198A1
(fr)
|
2004-12-30 |
2006-07-06 |
Astex Therapeutics Limited |
Derives pyrazoliques modulant l'activite des kinases cdk, gsk et aurora
|
GB0500492D0
(en)
|
2005-01-11 |
2005-02-16 |
Cyclacel Ltd |
Compound
|
GB0504475D0
(en)
|
2005-03-04 |
2005-04-13 |
Astrazeneca Ab |
Chemical compounds
|
FR2882751B1
(fr)
|
2005-03-04 |
2007-09-14 |
Aventis Pharma Sa |
Hydrazinocarbonyl-thieno[2,3-c]pyrazoles, procede de preparation, compositions les contenant et utilisation
|
GB0504474D0
(en)
|
2005-03-04 |
2005-04-13 |
Astrazeneca Ab |
Chemical compounds
|
FR2884821B1
(fr)
*
|
2005-04-26 |
2007-07-06 |
Aventis Pharma Sa |
Pyrrolopyridines substitues, compositions les contenant, procede de fabrication et utilisation
|
GB0509224D0
(en)
|
2005-05-05 |
2005-06-15 |
Chroma Therapeutics Ltd |
Inhibitors of intracellular enzymatic activity
|
GB0509227D0
(en)
|
2005-05-05 |
2005-06-15 |
Chroma Therapeutics Ltd |
Intracellular enzyme inhibitors
|
GB0509223D0
(en)
|
2005-05-05 |
2005-06-15 |
Chroma Therapeutics Ltd |
Enzyme inhibitors
|
US7541367B2
(en)
|
2005-05-31 |
2009-06-02 |
Janssen Pharmaceutica, N.V. |
3-benzoimidazolyl-pyrazolopyridines useful in treating kinase disorders
|
JP2008542433A
(ja)
*
|
2005-06-09 |
2008-11-27 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
CDK−1インヒビターとしてのα−カルボリン
|
US8119655B2
(en)
*
|
2005-10-07 |
2012-02-21 |
Takeda Pharmaceutical Company Limited |
Kinase inhibitors
|
JP2010505961A
(ja)
*
|
2006-10-09 |
2010-02-25 |
タケダ サン ディエゴ インコーポレイテッド |
キナーゼ阻害剤
|